Joseph Schwarz, Ph.D.
Founder & Chief Executive Officer, Pharcon Inc.
Professional Overview
Joseph Schwarz, Ph.D., is a pharmaceutical scientist and technology expert, best known for his leadership and scientific roles in companies focused on drug delivery technologies and formulation development.
Education
- Ph.D. in Chemistry from the Zelinsky Organic Chemistry Institute, Russian Academy of Sciences, with graduate coursework in polymer chemistry at Moscow State University.
Professional Experience
Joseph Schwarz has over 20 years of experience in pharmaceutical R&D, with deep expertise in drug formulation and controlled release technologies. His research and leadership span both scientific and managerial roles:
- Chief Scientific Officer, PHARCON Inc. (previously Chief Scientist before becoming CEO).
- Chief Scientist at AlphaRx Canada (2004–2011), a specialty pharmaceutical company focused on advanced drug delivery.
- Senior Management roles in formulation development at Novopharm Pharmaceuticals Ltd. (early 2000s).
- Senior Scientist positions at established pharma firms, including:
- Pharmos Ltd. (U.S.)
- TEVA Pharmaceuticals Ltd.
- D-PHARM (Israel)
These roles focused on R&D in drug formulation and delivery systems across oral, topical, and other administration routes.
Scientific Contributions
Dr. Schwarz is recognized for his extensive contributions to pharmaceutical science, including:
- Published more than 40 peer-reviewed scientific articles in pharmaceutical and drug delivery research.
- Authored 20+ U.S. patents and patent applications covering controlled release and advanced drug delivery technologies.
Areas of Expertise
- Controlled-release drug delivery systems (oral, topical, ophthalmic, parenteral)
- Biodegradable nano- and microparticles for drug delivery
- Colloidal systems (nanoemulsions, micelles, hybrid nanoparticles)
- Pharmaceutical development for small molecules, peptides, and proteins
